Literature DB >> 12874102

Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice.

John D Porter1, Anita P Merriam, Patrick Leahy, Bendi Gong, Sangeeta Khanna.   

Abstract

Although dystrophin mutations are the proximate cause of Duchenne muscular dystrophy (DMD), interactions among heterogeneous downstream mechanisms may be key phenotypic determinants. Temporal gene expression profiling was used to identify and correlate diverse transcriptional patterns to one another and to the disease course, for both affected and spared muscle groups, in postnatal day 7-112 dystrophin-deficient (mdx) mice. While 719 transcripts were differentially expressed at one or more ages in leg muscle, only 56 genes were altered in the spared extraocular muscles (EOM). Contrasting molecular signatures of affected versus spared muscles provide compelling evidence that the absence of dystrophin alone is necessary but not sufficient to cause the patterned fibrosis, inflammation and failure of muscle regeneration characteristic of dystrophinopathy. Dystrophic and adaptive changes in the microarray profiles were further quantified using an aggregate disease load index (DLI) to measure stage-dependent transcriptional impact in both muscles. DLI analysis highlighted the divergent responses of EOM and leg muscle groups. Cellular process-specific DLIs in leg muscle identified positively correlated temporal expression profiles for some gene classes, and the independence of others, that are linked to major disease components. Data also showed a previously unrecognized transient and selective developmental delay in pre-necrotic mdx skeletal muscle that was confirmed by qPCR. Taken together, validation and targeting of signaling pathways responsible for the coordination of the fibrotic, proteolytic and inflammatory mechanisms shown here for mdx muscle may yield new therapeutic means of mitigating the devastating consequences of DMD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874102     DOI: 10.1093/hmg/ddg197

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  42 in total

1.  Genomic profiling reveals Pitx2 controls expression of mature extraocular muscle contraction-related genes.

Authors:  Yuefang Zhou; Bendi Gong; Henry J Kaminski
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-18       Impact factor: 4.799

2.  Sparing of the extraocular muscles in mdx mice with absent or reduced utrophin expression: A life span analysis.

Authors:  Abby A McDonald; Sadie L Hebert; Linda K McLoon
Journal:  Neuromuscul Disord       Date:  2015-09-06       Impact factor: 4.296

3.  Role of the cytoskeleton in muscle transcriptional responses to altered use.

Authors:  Gretchen A Meyer; Simon Schenk; Richard L Lieber
Journal:  Physiol Genomics       Date:  2013-02-26       Impact factor: 3.107

4.  Transcription factor NF-κB regulates expression of pore-forming Ca2+ channel unit, Orai1, and its activator, STIM1, to control Ca2+ entry and affect cellular functions.

Authors:  Anja Eylenstein; Sebastian Schmidt; Shuchen Gu; Wenting Yang; Evi Schmid; Eva-Maria Schmidt; Ioana Alesutan; Kalina Szteyn; Ivonne Regel; Ekaterina Shumilina; Florian Lang
Journal:  J Biol Chem       Date:  2011-11-21       Impact factor: 5.157

Review 5.  Gene therapy in large animal models of muscular dystrophy.

Authors:  Zejing Wang; Jeffrey S Chamberlain; Stephen J Tapscott; Rainer Storb
Journal:  ILAR J       Date:  2009

Review 6.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014

7.  Transcriptomic analysis of dystrophin RNAi knockdown reveals a central role for dystrophin in muscle differentiation and contractile apparatus organization.

Authors:  Mohammad M Ghahramani Seno; Capucine Trollet; Takis Athanasopoulos; Ian R Graham; Pingzhao Hu; George Dickson
Journal:  BMC Genomics       Date:  2010-06-01       Impact factor: 3.969

8.  Evaluation of skeletal and cardiac muscle function after chronic administration of thymosin beta-4 in the dystrophin deficient mouse.

Authors:  Christopher F Spurney; Hee-Jae Cha; Arpana Sali; Gouri S Pandey; Emidio Pistilli; Alfredo D Guerron; Heather Gordish-Dressman; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

Review 9.  Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention.

Authors:  Nicholas P Evans; Sarah A Misyak; John L Robertson; Josep Bassaganya-Riera; Robert W Grange
Journal:  PM R       Date:  2009-08       Impact factor: 2.298

10.  Protein-DNA array-based identification of transcription factor activities differentially regulated in skeletal muscle of normal and dystrophin-deficient mdx mice.

Authors:  Charu Dogra; Daya Shankar Srivastava; Ashok Kumar
Journal:  Mol Cell Biochem       Date:  2008-02-17       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.